EXPRESSION OF LAMININ AND TYPE-IV COLLAGEN BY BASEMENT MEMBRANE-PRODUCING EHS TUMORS IN STREPTOZOTOCIN-INDUCED DIABETIC MICE - IN-VIVO MODULATION BY LOW-MOLECULAR-WEIGHT HEPARIN FRAGMENTS
C. Asselotchapel et al., EXPRESSION OF LAMININ AND TYPE-IV COLLAGEN BY BASEMENT MEMBRANE-PRODUCING EHS TUMORS IN STREPTOZOTOCIN-INDUCED DIABETIC MICE - IN-VIVO MODULATION BY LOW-MOLECULAR-WEIGHT HEPARIN FRAGMENTS, Biochemical pharmacology, 52(11), 1996, pp. 1695-1701
The biosynthesis of basement membrane components in Engelbreth Helm Sw
arm-bearing mice with or without streptozotocin-induced diabetes and t
he effect of low-molecular-weight heparin derivatives (CY222, Sanofi R
echerche/Institut Choay) on the relative rates of these synthetic acti
vities were studied. In diabetic mice, the laminin mRNA level increase
d, whereas type IV collagen mRNA decreased. In vivo treatment with hep
arin fragments decreased the mRNA level of laminin to control values w
ithout altering the mRNA level of collagen IV. Biosynthetic studies wi
th radiolabeled precursors ([H-3]-proline for collagen and [S-35]-meth
ionine for laminin) confirmed these results. Laminin protein biosynthe
sis increased in diabetic mice. Treatment with CY222 corrected this al
teration. Our results suggested an increased labeling of polymeric for
ms of collagen IV in diabetic mice. In addition, we showed that biosyn
thesis of acid-extractable collagen IV decreased in diabetic mice and
that CY222 treatment corrected this disturbance. These experiments sug
gest that low-molecular-weight heparin fragments CY222 can modulate th
e biosynthesis of extracellular matrix macromolecules altered in diabe
tic animals by different pathways, including pretranslational and post
translational steps. Copyright (C) 1996 Elsevier Science Inc.